Vir Biotechnology, Inc. (VIR) Institutional Ownership

Ownership Summary

Vir Biotechnology, Inc. (NASDAQ:VIR) currently has 206 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• These investors collectively held 72.2% of the company's total shares outstanding in December 2025, down from 76.7% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 15.66%, with a year-over-year a decrease of 1.44% in the count of filers.
• Among the 206 institutional holders of Vir Biotechnology, 95 added to their stakes while 71 trimmed their positions and 40 held steady.
• The total number of shares held by institutions in Vir Biotechnology increased to 100.65Mn as of December 2025, a net change of up by 13.63Mn shares quarter on quarter, and up 11.63Mn shares year over year.
• BlackRock, Inc. continues to be the largest institutional holder of Vir Biotechnology as of December 31, 2025, with a position of 16.33Mn shares, representing 11.71% of the company's outstanding stock.
• Among the most significant buyers of Vir Biotechnology during December 2025 were GSK plc (8.55Mn), BALYASNY ASSET MANAGEMENT L.P. (1.37Mn), Candriam S.C.A. (1.03Mn), STATE STREET CORP (988.26K), GordonMD Global Investments LP (930.32K).
• Leading sellers of Vir Biotechnology stock in December 2025 included ROYAL BANK OF CANADA (711.64K), RENAISSANCE TECHNOLOGIES LLC (552.64K), FMR LLC (478.71K), DIMENSIONAL FUND ADVISORS LP (442.59K), MILLENNIUM MANAGEMENT LLC (393.90K).
• The top 10 institutional holders of Vir Biotechnology for the quarter ending December 2025 included BlackRock, Inc. (16.33Mn), ARCH Venture Management, LLC (12.92Mn), VANGUARD GROUP INC (12.55Mn), GSK plc (8.55Mn), STATE STREET CORP (6.23Mn), FMR LLC (3.16Mn), MORGAN STANLEY (2.68Mn), DIMENSIONAL FUND ADVISORS LP (2.54Mn), ORBIMED ADVISORS LLC (2.38Mn), GEODE CAPITAL MANAGEMENT, LLC (2.33Mn).